A Double-Blind, Crossover Study to Assess the Effects of Nebulized Brovana Added to Tiotropium on FEV1, Hyperinflation, and Exercise Endurance Capacity in COPD
Phase of Trial: Phase IV
Latest Information Update: 15 Jun 2015
At a glance
- Drugs Arformoterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 17 Jul 2012 Actual end date May 2009 added as reported by ClinicalTrials.gov.
- 09 Feb 2011 New trial record
- 01 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.